275 related articles for article (PubMed ID: 19414743)
1. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
[TBL] [Abstract][Full Text] [Related]
2. GRAIL and Otubain-1 are Related to T Cell Hyporesponsiveness during Trypanosoma cruzi Infection.
Stempin CC; Rojas Marquez JD; Ana Y; Cerban FM
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005307. PubMed ID: 28114324
[TBL] [Abstract][Full Text] [Related]
3. Evidence implicating the Ras pathway in multiple CD28 costimulatory functions in CD4+ T cells.
Janardhan SV; Praveen K; Marks R; Gajewski TF
PLoS One; 2011; 6(9):e24931. PubMed ID: 21949793
[TBL] [Abstract][Full Text] [Related]
4. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
Colombetti S; Basso V; Mueller DL; Mondino A
J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
[TBL] [Abstract][Full Text] [Related]
5. Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.
Sande OJ; Karim AF; Li Q; Ding X; Harding CV; Rojas RE; Boom WH
J Immunol; 2016 Jan; 196(2):691-702. PubMed ID: 26667170
[TBL] [Abstract][Full Text] [Related]
6. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells.
Seroogy CM; Soares L; Ranheim EA; Su L; Holness C; Bloom D; Fathman CG
J Immunol; 2004 Jul; 173(1):79-85. PubMed ID: 15210761
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Matsuzawa Y; Oshima S; Takahara M; Maeyashiki C; Nemoto Y; Kobayashi M; Nibe Y; Nozaki K; Nagaishi T; Okamoto R; Tsuchiya K; Nakamura T; Ma A; Watanabe M
Autophagy; 2015; 11(7):1052-62. PubMed ID: 26043155
[TBL] [Abstract][Full Text] [Related]
8. Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.
Schartner JM; Simonson WT; Wernimont SA; Nettenstrom LM; Huttenlocher A; Seroogy CM
J Biol Chem; 2009 Dec; 284(50):34674-81. PubMed ID: 19833735
[TBL] [Abstract][Full Text] [Related]
9. GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells.
Anandasabapathy N; Ford GS; Bloom D; Holness C; Paragas V; Seroogy C; Skrenta H; Hollenhorst M; Fathman CG; Soares L
Immunity; 2003 Apr; 18(4):535-47. PubMed ID: 12705856
[TBL] [Abstract][Full Text] [Related]
10. The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
Su LL; Iwai H; Lin JT; Fathman CG
J Immunol; 2009 Jul; 183(1):438-44. PubMed ID: 19542455
[TBL] [Abstract][Full Text] [Related]
11. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
[TBL] [Abstract][Full Text] [Related]
12. In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
Lupino E; Buccinnà B; Ramondetti C; Lomartire A; De Marco G; Ricotti E; Tovo PA; Rinaudo MT; Piccinini M
Immunology; 2010 Oct; 131(2):231-41. PubMed ID: 20465575
[TBL] [Abstract][Full Text] [Related]
13. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.
Nurieva RI; Zheng S; Jin W; Chung Y; Zhang Y; Martinez GJ; Reynolds JM; Wang SL; Lin X; Sun SC; Lozano G; Dong C
Immunity; 2010 May; 32(5):670-80. PubMed ID: 20493730
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.
Kriegel MA; Rathinam C; Flavell RA
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16770-5. PubMed ID: 19805371
[TBL] [Abstract][Full Text] [Related]
16. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
Efimova OV; Kelley TW
BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
[TBL] [Abstract][Full Text] [Related]
17. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
Turner MS; Kane LP; Morel PA
J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
[TBL] [Abstract][Full Text] [Related]
18. A role for mammalian target of rapamycin in regulating T cell activation versus anergy.
Zheng Y; Collins SL; Lutz MA; Allen AN; Kole TP; Zarek PE; Powell JD
J Immunol; 2007 Feb; 178(4):2163-70. PubMed ID: 17277121
[TBL] [Abstract][Full Text] [Related]
19. CD28 co-stimulatory signals induce IL-2 receptor expression on antigen-stimulated virgin T cells by an IL-2-independent mechanism.
Toyooka K; Maruo S; Iwahori T; Yamamoto N; Tai XG; Abe R; Takahama Y; Murakami M; Uede T; Hamaoka T; Fujiwara H
Int Immunol; 1996 Feb; 8(2):159-69. PubMed ID: 8671600
[TBL] [Abstract][Full Text] [Related]
20. Two isoforms of otubain 1 regulate T cell anergy via GRAIL.
Soares L; Seroogy C; Skrenta H; Anandasabapathy N; Lovelace P; Chung CD; Engleman E; Fathman CG
Nat Immunol; 2004 Jan; 5(1):45-54. PubMed ID: 14661020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
